Prostate Health Index

Prostate Health Index

WHAT IS phi ?

The prostate health index (phi) is a mathematical formula that provides a probability of prostate cancer (PCa) by combining three tests (prostate-specific antigen [PSA], free PSA, and p2PSA) into a single score. Calculated by using an algorithm in the Beckman Coulter Access instrument, the phi score can provide more accurate information about the meaning of an elevated PSA level and the probability of finding prostate cancer on a biopsy.

Details

Category:
  • Description

Description

BETTER PROSTATE CANCER DETECTION

While PSA is a widely used screening tool for prostate cancer, its limited specificity for cancer necessitates a more precise tool for prostate cancer detection. Phi is intended to fill the diagnostic “gap” between PSA screening and a prostate biopsy. Combined with family and patient history, the phi can be used to determine the best individualized patient-management decisions for those diagnosed with prostate cancer. The higher specificity of phi means a greater probability of identifying those patients who actually need a biopsy, allowing for a substantial decrease in the current number of prostate biopsies being ordered and reported as negative for cancer.

HOW IS phi REIMBURSED?

The calculation of phi is similar to the calculation of %fPSA. From a coding and reimbursement perspective, the difference is that for phi, the American Urological Association (AUA) recommends using CPT code 86316 for the new test of p2PSA. There currently is no separate CPT code for the calculation of the phi value. The AUA Coding and Reimbursement Committee recommends that if each of the prostate cancer blood tests is performed, then CPT codes 84153 (PSA Total), 84154 (Free PSA), and 86316 (p2PSA) should be reported.

Details